Prepared as a catalog companion to the model testing report.
Ingredient list
Declared composition for a LIRAVEXIN catalog item — not a tested result
Declared ingredients
| Ingredient | Amount as declared | Public identity |
|---|---|---|
| Cagrilintide | 5 mg | A long-acting amylin analogue, as named in the public scientific literature. |
| Semaglutide | 5 mg | A long-acting glucagon-like peptide-1 (GLP-1) receptor agonist. Public structural description: a GLP-1(7–37) analogue with 2-aminoisobutyric acid at position 8 and a C18 diacid chain attached at Lys26 via a γ-glutamate and two AEEA spacers. Public sequence / structure: His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEA-AEEA-γ-Glu-17-carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly |
| Other constituents | — | Not declared on the catalog label. No excipient (for example a bulking agent, counter-ion or residual moisture) is assumed here. |
Amino-acid sequences, where shown, are well-known public identities of the named substance. If a sequence could not be stated with confidence, it has been omitted rather than guessed.
Permalink
The QR code on the model report opens this page.
Published address:
https://gs-laboratory.com/ingredients/cs10.html
This is the published address of this ingredient list.
Notes
This ingredient list is a declared composition for the catalog item. It is not a Certificate of Analysis and not a statement of purity, identity or content as measured in a laboratory.
The catalog item is a research product, not a medicinal product. This page is not medical advice, not a dosing guide, and not a marketing claim. GS Laboratory does not manufacture or sell peptides or medicines.